Regeneus to be granted key Progenza patent in Europe
Filed with ASX · · 1 page · English
Story so far
Earlier from Cambium Bio
- Regeneus Company Update Investor Webcast Presentation
- Half-Year Results and Business Update
- Appendix 4D and Half-Year Report
- Regeneus to be granted new patent to target pain in Japan
- Response to ASX Appendix 4C Query
Later from Cambium Bio
- Regeneus partners with Defence to treat combat casualties
- Appendix 4C - Quarterly
- Regeneus Announces Institutional Placement
- Regeneus Market Update
- Grant of ASX Waiver
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio